These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21071935)

  • 1. Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy.
    Fu Y; Zhang Y; Wang Z; Wang L; Wei X; Zhang B; Wen Z; Fang H; Pang Q; Yi F
    Am J Nephrol; 2010; 32(6):581-9. PubMed ID: 21071935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalizing NADPH oxidase contributes to attenuating diabetic nephropathy by the dual endothelin receptor antagonist CPU0213 in rats.
    Xu M; Dai DZ; Dai Y
    Am J Nephrol; 2009; 29(3):252-6. PubMed ID: 18802327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells.
    Jaulmes A; Sansilvestri-Morel P; Rolland-Valognes G; Bernhardt F; Gaertner R; Lockhart BP; Cordi A; Wierzbicki M; Rupin A; Verbeuren TJ
    Thromb Res; 2009 Sep; 124(4):439-46. PubMed ID: 19540572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle.
    Ellmark SH; Dusting GJ; Fui MN; Guzzo-Pernell N; Drummond GR
    Cardiovasc Res; 2005 Feb; 65(2):495-504. PubMed ID: 15639489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naringin ameliorates diabetic nephropathy by inhibiting NADPH oxidase 4.
    Zhang J; Yang S; Li H; Chen F; Shi J
    Eur J Pharmacol; 2017 Jun; 804():1-6. PubMed ID: 28395989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of NOD2 as a novel target of RNA-binding protein HuR: evidence from NADPH oxidase-mediated HuR signaling in diabetic nephropathy.
    Shang J; Wan Q; Wang X; Duan Y; Wang Z; Wei X; Zhang Y; Wang H; Wang R; Yi F
    Free Radic Biol Med; 2015 Feb; 79():217-27. PubMed ID: 25528059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia.
    Vallet P; Charnay Y; Steger K; Ogier-Denis E; Kovari E; Herrmann F; Michel JP; Szanto I
    Neuroscience; 2005; 132(2):233-8. PubMed ID: 15802177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS.
    Ding H; Hashem M; Triggle C
    Eur J Pharmacol; 2007 Apr; 561(1-3):121-8. PubMed ID: 17292348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation.
    Luo ZF; Feng B; Mu J; Qi W; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH
    Toxicol Appl Pharmacol; 2010 Jul; 246(1-2):49-57. PubMed ID: 20399799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of losartan on cyclooxygenase-2 expression in normal human mesangial cells and kidneys of rats with diabetic nephropathy.
    Zhou QL; Peng WS; Yuichiro Y; Liu ZC; Yang JH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):790-9. PubMed ID: 18812657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: effects of apocynin.
    Qin F; Patel R; Yan C; Liu W
    Free Radic Biol Med; 2006 Jan; 40(2):236-46. PubMed ID: 16413406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase.
    Ago T; Kitazono T; Ooboshi H; Iyama T; Han YH; Takada J; Wakisaka M; Ibayashi S; Utsumi H; Iida M
    Circulation; 2004 Jan; 109(2):227-33. PubMed ID: 14718399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries.
    Miller AA; Drummond GR; Schmidt HH; Sobey CG
    Circ Res; 2005 Nov; 97(10):1055-62. PubMed ID: 16210546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4.
    Wendt MC; Daiber A; Kleschyov AL; Mülsch A; Sydow K; Schulz E; Chen K; Keaney JF; Lassègue B; Walter U; Griendling KK; Münzel T
    Free Radic Biol Med; 2005 Aug; 39(3):381-91. PubMed ID: 15993337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity.
    Carmona-Cuenca I; Roncero C; Sancho P; Caja L; Fausto N; Fernández M; Fabregat I
    J Hepatol; 2008 Dec; 49(6):965-76. PubMed ID: 18845355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superoxide production and NADPH oxidase expression in human rheumatoid synovial cells: regulation by interleukin-1beta and tumour necrosis factor-alpha.
    Chenevier-Gobeaux C; Lemarechal H; Bonnefont-Rousselot D; Poiraudeau S; Ekindjian OG; Borderie D
    Inflamm Res; 2006 Nov; 55(11):483-90. PubMed ID: 17122966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin.
    Wang C; Li J; Lv X; Zhang M; Song Y; Chen L; Liu Y
    Eur J Pharmacol; 2009 Oct; 620(1-3):131-7. PubMed ID: 19686728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Nox4 in osteoclasts.
    Yang S; Zhang Y; Ries W; Key L
    J Cell Biochem; 2004 May; 92(2):238-48. PubMed ID: 15108351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.